GB9424902D0 — Solubilisation Aids
Assigned to Cortecs Ltd · Expires 1995-02-08 · 31y expired
What this patent protects
The invention provides a process for the preparation of a single phase hyudrophobic preparation comprising a hydrophilic species in a hydrophobic solvent wherein a compound which is: (a) a low molecular weight compound having at least some degree of polarity; and/or (b) a lipid-s…
USPTO Abstract
The invention provides a process for the preparation of a single phase hyudrophobic preparation comprising a hydrophilic species in a hydrophobic solvent wherein a compound which is: (a) a low molecular weight compound having at least some degree of polarity; and/or (b) a lipid-soluble organic acid; and/or (c) an amphiphile; and (d) glycerol or other polyhydric alcohols; is added during the process to aid solubilisation.
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.